Exactech Announces First International Introduction of ExactechGPS® Guided Personalized Surgery at 15th EFORT Congress
June 04 2014 - 8:24AM
Business Wire
Live Demonstrations to Feature Practical
Experience with Exactech’s Latest Innovations
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today its slate of products to be
featured at the company’s technical exhibit, Capital Hall, Booth
#16, at the 15th Annual Congress of the European Federation of
National Associations of Orthopaedics and Traumatology (EFORT) June
4-6 in London.
Exactech Knee
Since 1994, the Exactech Knee system has demonstrated
“Performance over Time” with its proven design, proprietary
materials and excellent long-term clinical results.1
The company is celebrating 20 years of Exactech Knee with its
first international introduction of ExactechGPS® -- Guided
Personalized Surgery, the first advanced surgical technology to
provide a real-time patient-specific solution in total knee
arthroplasty. With a touch screen in the sterile field, ExactechGPS
puts real-time visual guidance and alignment data at the surgeon’s
fingertips. Customized for surgeon preferences, ExactechGPS is a
powerful addition to the surgical team in addressing their goals of
efficacy, efficiency and economics.
Exactech’s educational exhibit features a surgical skills area
that will allow clinicians to see live demonstrations of
ExactechGPS and to gain hands-on experience with this advanced
surgical technology and the Optetrak Logic® knee system.
Exactech is also introducing Optetrak Logic Porous PS, which
offers a textured, CoCr coating option with increased average pore
size and greater porosity than traditional spherical beads.2
Exactech Hip
Exactech Hip solutions address the continuum of hip
arthroplasty. The Exactech Hip portfolio includes solutions for
primary, fracture and revision hip reconstruction.
Exactech Shoulder
Nine years of clinical use and 32 peer-reviewed studies
demonstrate that Exactech had it “Right from the Start.” The EFORT
Congress is the ideal time to learn more about Exactech’s Equinoxe®
Platform Shoulder System — the fastest growing shoulder system in
the industry. At EFORT, Exactech introduces the Equinoxe® Cage
Glenoid, designed to offer several benefits including minimized
operating room time and enhanced fixation through interference fit
of the plasma coated central cage.
Exactech Biologics
Exactech recognizes the growing importance of biologic solutions
for orthopaedics. Come by the Exactech booth to learn about:
- Optecure® bone matrix and the
flexibility of combining with saline, blood, autogenous bone marrow
and autologous bone graft.
- Accelerate® Concentrating System:
Designed for the safe and rapid preparation of autologous platelet
rich plasma (PRP) from a small sample of blood at the patient’s
point of care.
Surgeon experts on Exactech Knee, ExactechGPS and Exactech
Biologics will be available for appointments at the exhibit to
discuss their experiences, the technical aspects of Exactech
products and solutions for clinical challenges with EFORT
attendees.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
References
1. Data on file at Exactech, Inc. Exactech Knee Literature
Review.
2. Data on file at Exactech.
Exactech Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.comorExactech Inc.Media
contactPriscilla Bennett, 352-377-1140Director Marketing
Communication & Public Relations
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024